paclitaxel has been researched along with Esophageal Stricture in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Du, RJ; He, SC; Ji, JJ; Liu, DF; Liu, LL; Lu, LG; Pan, T; Qin, J; Teng, GJ; Yang, J; Zeng, CH; Zhu, HD | 1 |
| Fujimoto, A; Ichinose, Y; Matsuura, K; Nukui, A; Osaki, A; Saeki, T | 1 |
| Cheng, Y; Cui, W; Hu, C; Li, B; Yang, H; Zhu, Y | 1 |
| Chen, NW; Cheng, YS; Cui, WG; Wang, L; Zhu, YQ | 1 |
| Cho, JY; Eun, SH; Jeon, SR; Jin, SY; Kim, JO; Lee, JS; Lee, MS; Ryu, CB; Shim, CS | 1 |
| Abdel-Wahab, M; Abitbol, A; Hamilton, K; Lewin, A; Markoe, A; Troner, M | 1 |
1 trial(s) available for paclitaxel and Esophageal Stricture
| Article | Year |
|---|---|
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Drug Eruptions; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Gastrostomy; Head and Neck Neoplasms; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Radiotherapy, Adjuvant; Surveys and Questionnaires; Survival Rate | 2005 |
5 other study(ies) available for paclitaxel and Esophageal Stricture
| Article | Year |
|---|---|
Biodegradable PTX-PLGA-coated magnesium stent for benign esophageal stricture: An experimental study.
Topics: Animals; Esophageal Stenosis; Magnesium; Paclitaxel; Polymers; Rabbits; Stents | 2022 |
[Patient with Recurrent Breast Cancer Who Developed Radiation Esophagitis with Severe Esophageal Stenosis after Combined Bevacizumab and Paclitaxel Therapy-A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Esophageal Stenosis; Esophagitis; Female; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patients; Positron Emission Tomography Computed Tomography; Radiation | 2020 |
A highly flexible paclitaxel-loaded poly(ε-caprolactone) electrospun fibrous-membrane-covered stent for benign cardia stricture.
Topics: Animals; Delayed-Action Preparations; Diffusion; Dogs; Drug-Eluting Stents; Elastic Modulus; Electrochemistry; Equipment Design; Equipment Failure Analysis; Esophageal Stenosis; Esophagitis; Female; Male; Materials Testing; Membranes, Artificial; Nanofibers; Paclitaxel; Polyesters; Rotation; Surface Properties; Treatment Outcome | 2013 |
Temporary placement of a paclitaxel or rapamycin-eluting stent is effective to reduce stenting induced inflammatory reaction and scaring in benign cardia stricture models.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cardia; Cicatrix; Constriction, Pathologic; Disease Models, Animal; Dogs; Drug-Eluting Stents; Esophageal Sphincter, Lower; Esophageal Stenosis; Female; Humans; Inflammation; Male; Manometry; Paclitaxel; Random Allocation; Sirolimus; Time Factors | 2014 |
Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study.
Topics: Alloys; Animals; Antineoplastic Agents, Phytogenic; Cell Division; Disease Models, Animal; Dogs; Drug-Eluting Stents; Epithelium; Equipment Design; Esophageal Stenosis; Esophagoscopy; Esophagus; Focal Adhesions; Granulation Tissue; Mucous Membrane; Paclitaxel | 2009 |